CYBB and chronic granulomatous disease: The primary motivation for investigating the clinical effects of IFN-γ in CGD was its experimentally observed enhancement of O2- production by Nox2 [2] suggesting that patients with reduced expression of a phox protein might benefit from IFN-γ administration.